Antiviral chemistry & chemotherapy · 1998 · 43 citations · 18 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular VirologyProdrug DesignAntiretroviral TherapyAntiviral AgentsAntiviral PharmacologyAntiviral Prodrug DesignAntiviral TherapyAntiviral Drug DesignAntiviral Structure-activity RelationshipsEsterase ActivityEsterase-mediated HydrolysisHydrolysisIn-vitro CharacterizationNucleoside AnalogsNucleoside Analogue Antivirals
Novel chain-extended nucleoside phosphoramidates of the anti-human immunodeficiency virus (HIV) drug d4T (stavudine) have been prepared as possible membrane-permeable prodrugs of the bio-active free 5'-monophosphates. Phosphorochloridate chemistry gave the target compounds in moderate to high yields, and all materials were fully characterized by spectroscopic and analytical methods. The compounds are related to the previously reported phenyl methoxyalaninyl derivative of d4T, which was shown to be a potent and selective inhibitor of HIV. In this study the amino acid nitrogen and ester moieties were separated by methylene spacers of between two and six carbon atoms. In vitro evaluation of these compounds indicated an almost complete lack of anti-HIV activity, the compounds being several orders of magnitude less potent than the corresponding alpha-amino acid derivatives. The reasons for the virtual lack of anti-HIV activity appear to involve poor enzyme-mediated hydrolysis.
18
L L Iversen · Nature New Biology · 1971 · 812 citations
Jan Balzarini, Antonı́n Holý, Jindřich Jindřich et al. · Antimicrobial Agents and Chemotherapy · 1993 · 345 citations
Christopher McGuigan, Dominique Cahard, Hendrika M. Sheeka et al. · Journal of Medicinal Chemistry · 1996 · 228 citations
Christian Périgaud, Gilles Gosselin, Isabelle Lefèbvre et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 114 citations